Tags : Semi-Quantitative SARS-CoV-2 IgG Antibody Test

The US FDA Grants EUA for Quanterix’s Simoa Semi-Quantitative SARS-CoV-2

Vartika Singh December 31, 2020

Shots: The FDA has issued a EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Ab test and can be operated on Simoa HD-X Analyzer The test checks for Abs that are directed […]readmore

Tags : Semi-Quantitative SARS-CoV-2 IgG Antibody Test

The US FDA Grants EUA for Quanterix’s Simoa Semi-Quantitative SARS-CoV-2

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Semi-Quantitative SARS-CoV-2 IgG Antibody Test

The US FDA Grants EUA for Quanterix’s Simoa Semi-Quantitative SARS-CoV-2

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company